Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.

Alexander KutzAnna ConenClaudia GregorianoSebastian HaubitzDaniel KochOliver DomenigLuca BernasconiBeat MuellerPhilipp Schuetz

Published in: European journal of endocrinology (2021)

As compared with SARS-CoV-2-negative patients, we found a downregulated RAAS in presence of a SARS-CoV-2 infection. Whether the lower levels of the protective angiotensin (1-5) and (1-7) are linked to adverse outcomes in COVID-19 warrants further investigation.

Keyphrases

sars cov
angiotensin ii
angiotensin converting enzyme
respiratory syndrome coronavirus
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes